Detection and treatment of renal cell carcinoma with a SLC6A3 ligand linked to a label, cytotoxic or immunomodulatory group

The invention provides methods and material for diagnosis and treatment of ccRCC. Thus, the invention relates to a method for diagnosis or treatment of clear cell renal cell carcinoma (ccRCC) in an individual in an individual in need thereof, wherein the method comprises use of an SLC6A3 ligand link...

Full description

Saved in:
Bibliographic Details
Main Authors Axelson, Håkan, Johansson, Elinn, Lindgren, David, Gustavsson, Lena, Hansson, Jennifer
Format Patent
LanguageEnglish
Published 15.02.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides methods and material for diagnosis and treatment of ccRCC. Thus, the invention relates to a method for diagnosis or treatment of clear cell renal cell carcinoma (ccRCC) in an individual in an individual in need thereof, wherein the method comprises use of an SLC6A3 ligand linked to a radioactive label, a cytotoxic moiety or animmunomodulatory moiety.
Bibliography:Application Number: AU20160294377